Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Nuo Therapeutics, Inc. has filed 1,162 SEC EDGAR filings since 10 Dec 1999

SEC filing history

Showing 526-550 of 794 matching filings.

Per page
25
Current page
22
4

OWNERSHIP DOCUMENT

Filing date
03 Jul 2012
Reporting date
03 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jul 2012
Reporting date
03 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
02 Jul 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Jun 2012
Reporting date
18 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Jun 2012
Reporting date
18 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Jun 2012
Reporting date
18 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
13 Jun 2012
Reporting date
07 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-147793

424B3

Filing date
25 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-168936

424B3

Filing date
25 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170747

424B3

Filing date
25 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 May 2012
Reporting date
18 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
21 May 2012
Reporting date
18 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-147793

FORM 424B3

Filing date
18 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-168936

FORM 424B3

Filing date
18 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170747

FORM 424B3

Filing date
18 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 May 2012
Reporting date
03 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-147793

FORM POS EX

Filing date
19 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-168936

FORM POS EX

Filing date
19 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-170747

FORM POS EX

Filing date
19 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-168936

424B3 filing

Filing date
18 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170747

424B3 filing

Filing date
18 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-147793

424B3 filing

Filing date
18 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-170747

EFFECT filing

Filing date
17 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-168936

EFFECT filing

Filing date
17 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .